about
Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the ClinicThe clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases.Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: a case report with review of the literature.A case-control study of prevalence of anemia among patients with type 2 diabetesEarly Improvement in Marrow Fibrosis Following Haploidentical Stem Cell Transplantation for a Patient with Myelodysplastic Syndrome with Bone Marrow Fibrosis.Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis.Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report.TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis.[Myelodysplastic syndromes. Epidemiology, molecular and morphological characteristics and risk stratification].Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression.Bone marrow fibrosis at diagnosis is associated with TP53 overexpression and adverse prognosis in low-risk myelodysplastic syndrome.AKT Signaling Prevailing in Mesenchymal Stromal Cells Modulates the Functionality of Hematopoietic Stem Cells via Intercellular Communication.Setd2 regulates quiescence and differentiation of adult hematopoietic stem cells by restricting RNA polymerase II elongation.Cytokine Measurements for Diagnosing and Characterizing Leukemoid Reactions and Immunohistochemical Validation of a Granulocyte Colony-Stimulating Factor and CXCL8-Producing Renal Cell Carcinoma
P2860
Q26752778-FEA37593-D79F-4E8E-9A1E-A8EBB847DABBQ33407572-32E580AA-FB40-4655-BBA3-93C3982C3AAEQ33438202-558DF30A-9F24-4563-82DC-30161B9DD9E8Q36169249-55661A28-EB53-47FD-BB3F-C982D15A0180Q36866979-9725D5E0-E438-4E0B-B2DE-D2DF188D0CA9Q37521161-45674E39-B0E5-4172-BBFB-163377AE6C12Q37889846-09E00021-FBCA-4553-9DBC-67987F451A64Q38823803-3DAE0FF0-1FA7-43B9-908A-DB0F8DBECEBFQ41551475-BE7B0869-CA35-4C65-81E7-8334FF3BEC5BQ41572334-77F3CD8D-8F07-4B16-9462-0A03888F9CC6Q44325617-EF7E6A61-0D07-49A2-8949-197F71A1A77EQ47094379-17F7008D-8460-4D7E-A8C5-C1A1CC29C2B3Q48104500-CFB529CA-B4F5-49EC-9CDC-DD76E75362B8Q51703684-03C25DB1-BFB0-4692-B884-2F38CA7B1892Q52323123-FB48739D-073A-4ABC-BFCB-48E7819E7192Q58770354-68AFC3AA-CB8B-415E-AD70-051FD9E799AC
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Myelodysplastic syndromes with bone marrow fibrosis.
@en
Myelodysplastic syndromes with bone marrow fibrosis.
@nl
type
label
Myelodysplastic syndromes with bone marrow fibrosis.
@en
Myelodysplastic syndromes with bone marrow fibrosis.
@nl
prefLabel
Myelodysplastic syndromes with bone marrow fibrosis.
@en
Myelodysplastic syndromes with bone marrow fibrosis.
@nl
P2860
P1433
P1476
Myelodysplastic syndromes with bone marrow fibrosis.
@en
P2093
Luca Malcovati
Matteo Giovanni Della Porta
P2860
P304
P356
10.3324/HAEMATOL.2010.039875
P577
2011-02-01T00:00:00Z